New projects initiated over the past year have included:
- A pilot study which aims to determine whether a dietary product is well tolerated in a population of individuals with epilepsy.
- A randomised controlled trial which will assess whether early postoperative antiepileptic drug (AED) withdrawal improves cognitive function compared with late withdrawal.
- A Phase 3 observational study of Cannabidiol as a new treatment for drug resistant epilepsies.
- Further development of our work to integrate services and improve outcomes for young people with epilepsy. This work looks to develop a strategy for a new integrated model of care.
In addition we have, as a unit, been responsible for 70 peer-reviewed publications of primary research, as well as a further 24 publications of chapters, reviews and commentaries of expert opinion.
Under renewed strategic objectives, Young Epilepsy moves to deliver a dedicated education and social care research arm, strengthening our evidence base for service models internationally. As a unit, our research continues to work towards improving the recognition of epilepsy as a healthcare priority in every part of the world.
